American Heart Association Strengthens Leadership with New Board Appointments to Combat Heart Disease and Stroke

The American Heart Association has announced the appointment of Dr. Jennifer Ashton and Dr. Joseph Woo to its Board of Directors, effective July 1, 2025. This strategic move underscores the Association's dedication to addressing heart disease and stroke, the leading causes of death in the United States, by integrating clinical leadership, health media influence, and scientific innovation.

Dr. Ashton, a nationally recognized women’s health advocate and ABC News’ Chief Medical Correspondent, is known for her expertise in obesity medicine and preventive health. Her ability to communicate complex medical topics and her advocacy for women’s cardiovascular health are expected to significantly contribute to the Association's mission. Similarly, Dr. Woo, a pioneer in cardiac surgery innovation and professor at Stanford Medicine, brings to the board his extensive research and clinical trial experience, particularly in heart failure treatment through cellular repair.

Nancy Brown, CEO of the American Heart Association, highlighted the importance of these appointments, noting the unique perspectives Dr. Ashton and Dr. Woo will bring to the organization's efforts in transforming the future of health. Their expertise is anticipated to play a key role in advancing the Association's science-based solutions and community-centered approaches to tackling health challenges.

These appointments reflect the American Heart Association's commitment to building a healthier world through strategic leadership and collaboration. The Board of Directors is instrumental in guiding the organization's mission to promote longer, healthier lives, with its members serving as ambassadors to amplify its impact and visibility.